Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome

NCT02713945 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Noonan Syndrome

Interventions

DRUG: Simvastatin
DRUG: Placebo

Sponsor

University Hospital, Toulouse